EGFR mutations and molecularly targeted therapy:: a new era in the treatment of lung cancer

被引：15

作者：

Dowell, JE

Minna, JD

机构：

[1] Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA

[2] Dallas VA Med Ctr, Dallas, TX USA

[3] Univ Texas, SW Med Ctr, Ctr Canc Genet, Dallas, TX USA

[4] Univ Texas, SW Med Ctr, NCI Special Program Res Excellence, Dallas, TX USA

来源：

NATURE CLINICAL PRACTICE ONCOLOGY | 2006年 / 3卷 / 04期

关键词：

D O I：

10.1038/ncponc0476

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：170 / 171

页数：2

共 10 条

[1] Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer [J].

Cappuzzo, F ;

Hirsch, FR ;

Rossi, E ;

Bartolini, S ;

Ceresoli, GL ;

Bemis, L ;

Haney, J ;

Witta, S ;

Danenberg, K ;

Domenichini, I ;

Ludovini, V ;

Magrini, E ;

Gregorc, V ;

Doglioni, C ;

Sidoni, A ;

Tonato, M ;

Franklin, WA ;

Crino, L ;

Bunn, PA ;

Varella-Garcia, M .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (09) :643-655

[2] The impact of epidermal-growth-factor-receptor mutations in response to lung-cancer therapy [J].

Dowell, Jonathan E. ;

Minna, John D. .

NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (01) :2-3

[3] Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer [J].

Fukuoka, M ;

Yano, S ;

Giaccone, G ;

Tamura, T ;

Nakagawa, K ;

Douillard, JY ;

Nishiwaki, Y ;

Vansteenkiste, J ;

Kudoh, S ;

Rischin, D ;

Eek, R ;

Horai, T ;

Noda, K ;

Takata, I ;

Smit, E ;

Averbuch, S ;

Macleod, A ;

Feyereislova, A ;

Dong, RP ;

Baselga, J .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2237-2246

[4]

HIRSCH FR, 2005, P AACR NCI EORTC C M, P124

[5] Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer - A randomized trial [J].

Kris, MG ;

Natale, RB ;

Herbst, RS ;

Lynch, TJ ;

Prager, D ;

Belani, CP ;

Schiller, JH ;

Kelly, K ;

Spiridonidis, H ;

Sandler, A ;

Albain, KS ;

Cella, D ;

Wolf, MK ;

Averbuch, SD ;

Ochs, JJ ;

Kay, AC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (16) :2149-2158

[6] Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].

Lynch, TJ ;

Bell, DW ;

Sordella, R ;

Gurubhagavatula, S ;

Okimoto, RA ;

Brannigan, BW ;

Harris, PL ;

Haserlat, SM ;

Supko, JG ;

Haluska, FG ;

Louis, DN ;

Christiani, DC ;

Settleman, J ;

Haber, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139

[7] EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy [J].

Paez, JG ;

Jänne, PA ;

Lee, JC ;

Tracy, S ;

Greulich, H ;

Gabriel, S ;

Herman, P ;

Kaye, FJ ;

Lindeman, N ;

Boggon, TJ ;

Naoki, K ;

Sasaki, H ;

Fujii, Y ;

Eck, MJ ;

Sellers, WR ;

Johnson, BE ;

Meyerson, M .

SCIENCE, 2004, 304 (5676) :1497-1500

[8] Erlotinib in previously treated non-small-cell lung cancer [J].

Shepherd, FA ;

Pereira, JR ;

Ciuleanu, T ;

Tan, EH ;

Hirsh, V ;

Thongprasert, S ;

Campos, D ;

Maoleekoonpiroj, S ;

Smylie, M ;

Martins, R ;

van Kooten, M ;

Dediu, M ;

Findlay, B ;

Tu, DS ;

Johnston, D ;

Bezjak, A ;

Clark, G ;

Santabárbara, P ;

Seymour, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :123-132

[9] Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) [J].

Thatcher, N ;

Chang, A ;

Parikh, P ;

Pereira, JR ;

Ciuleanu, T ;

von Pawel, J ;

Thongprasert, S ;

Tan, EH ;

Pemberton, K ;

Archer, V ;

Carroll, K .

LANCET, 2005, 366 (9496) :1527-1537

[10] Erlotinib in lung cancer - Molecular and clinical predictors of outcome [J].

Tsao, MS ;

Sakurada, A ;

Cutz, JC ;

Zhu, CQ ;

Kamel-Reid, S ;

Squire, J ;

Lorimer, I ;

Zhang, T ;

Liu, N ;

Daneshmand, M ;

Marrano, P ;

Santos, GD ;

Lagarde, A ;

Richardson, F ;

Seymour, L ;

Whitehead, M ;

Ding, KY ;

Pater, J ;

Shepherd, FA .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :133-144

← 1 →